Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Maffrand

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studiesE Bignon, A Bachy, R Boigegrain, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studiesE Bignon, A Bachy, R Boigegrain, et al.
Pageof 12